Webinar
Explore the Depths of Radiomic Data in Clinical Trials
Join HealthMyne and Fierce Biotech for this interactive panel to explore the depths of radiomic data in clinical trials. Learn real world applications and practical strategies for radiomic use in clinical trials, personalized drug development and therapy response.
Please fill out the form to watch our Explore the Depths of Radiomic Data in Clinical Trials webinar
Webinar
Explore the Depths of Radiomic Data in Clinical Trials
Join HealthMyne and Fierce Biotech for this interactive panel to explore the depths of radiomic data in clinical trials. Learn real world applications and practical strategies for radiomic use in clinical trials, personalized drug development and therapy response.Please fill out the form to watch our Explore the Depths of Radiomic Data in Clinical Trials webinar
Access our radiomic resources and insights to help guide you.
Radiomic Solutions for Life Sciences
Explore the depths of your imaging data with our Radiomics solutions for Life Sciences
HealthMyne’s Radiomic Precision Metrics™ (RPM) and Radiomic Discovery Services
Our innovative AI and radiomic informed solutions can help your organization curate and digitize data from medical images as well as extract radiomic features to accelerate drug development and deliver real world evidence of therapy response. In addition, radiomic data can enhance and expand existing clinical trials and deliver precise endpoints to inform trial design, inclusion criteria and trial cohorts.
HealthMyne’s Radiomic Informed Therapy Response Module
HealthMyne provides radiomic informed workflow tools for documenting therapy and treatment response, ensuring appropriate clinical protocol assignment, disease progression monitoring and efficiently tracking patients through the trial process.
Analyze Real-World Evidence of Therapy Response
- Inform patient stratification and trial arm assignment
- Potential to increase trial availability
- Incorporate and automate trial protocol and reporting requirements
- Monitor disease progression and response to therapy
Enhance and Expand Existing Clinical Trials
- Incorporate radiomic insights in inclusion criteria and study design
- Leverage more precise and diverse endpoints for improved outcomes
- Measure radiomic data and response to therapy over time
Drive Value-based Clinical Outcomes
- Correlate clinical value and improved patient outcomes with therapy
- Transparency into patient population that will benefit from drug
- Support value-based contracting and reimbursement strategies